{"id":"W2011397767","doi":"10.1097/00001813-200302000-00001","title":"Neovastat—a novel antiangiogenic drug for cancer therapy","year":2003,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"","keywords":"Angiogenesis; Medicine; Drug; Clinical trial; Matrix metalloproteinase; Matrix metalloproteinase inhibitor; Multiple myeloma; Pharmacology; Cancer; Lung cancer; Apoptosis; Cancer research; Vascular endothelial growth factor; Oncology; Internal medicine; Biology; VEGF receptors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004691717,0.0009355663,0.001043604,0.001890303,0.0003262786,0.000797058,0.0009785841,0.001179989,0.003438851],"category_scores_gemma":[0.0002897943,0.0002443136,0.0003492587,0.001668448,0.0004693797,0.001285586,0.0004138432,0.001680868,0.003423716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006749913,"about_ca_system_score_gemma":0.0007174932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007584973,"about_ca_topic_score_gemma":0.001651813,"domain_scores_codex":[0.9998858,0.0000169148,0.00001113108,0.00001966489,0.00005265189,0.00001385877],"domain_scores_gemma":[0.9998891,0.0000369198,0.00001489903,0.000004862649,0.00003331985,0.00002083418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001084474,0.0001614206,0.0001992248,0.0035883,0.00005113264,0.0004357721,0.00003516038,0.000430107,0.004854159,0.002629376,0.03243915,0.9550677],"study_design_scores_gemma":[0.00005536958,0.000131252,0.0006080158,0.0005534228,0.00003194933,0.002396903,0.00002563893,0.000124129,0.001136506,0.001069987,0.9938536,0.00001322072],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004294419,0.9949632,0.000490246,0.0004129816,0.0003471964,0.00001589357,0.0000222305,0.00002562634,0.003293184],"genre_scores_gemma":[0.001934196,0.9943417,0.0006151884,0.0003759394,0.0002138117,0.00002171886,0.00005987746,0.000003736767,0.002433836],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003438851,"threshold_uncertainty_score":0.01150411,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05688579399434322,"score_gpt":0.3725090845438742,"score_spread":0.3156232905495309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}